Technology
Health
Pharmaceutical

Provention Bio

$2.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.83%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Provention Bio and other stocks, options, ETFs, and crypto commission-free!

About

Provention Bio, Inc. Common Stock, also called Provention Bio, is a clinical-stage biopharmaceutical company, which engages in the developement of biopharmaceutical products. Read More It focuses its product line on type 1 diabetes, Crohn's disease, ulcerative colitis, and emerging viral infections. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.

Employees
7
Headquarters
Lebanon, New Jersey
Founded
2016
Market Cap
89.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
57.54K
High Today
$2.49
Low Today
$2.34
Open Price
$2.49
Volume
32.90K
52 Week High
$8.00
52 Week Low
$1.52

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
Medical
2018 IPO
US
North America

News

PR Newswire10h

Provention Bio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

OLDWICK, N.J., March 19, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided a business update. "During 2018, we made great strides towards the achievement of our strategic goal of fundamentally changing the landscape for immune-mediated disease. In the span of twelve months, we augmente...

11
Simply Wall StMar 13

Are Insiders Buying Provention Bio, Inc. (NASDAQ:PRVB) Stock?

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Provention Bio, Inc. (NASDAQ:PRVB). Do Insider Transactions Matter? Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy a...

37
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.